HIV/AIDS Topics Black Men Who Have Sex with Men Have Higher HIV Rate despite Less Sexual Risk Behavior
- Details
- Category: HIV Sexual Transmission
- Published on Friday, 12 November 2010 00:00
- Written by Liz Highleyman
Black men who have sex with men have a far higher rate of HIV infection than other racial/ethnic groups in Washington, DC, even though they have fewer male sex partners, have less unprotected anal sex, and use condoms more often, according to an analysis described in the October 2010 issue of AIDS Patient Care and STDs. The reasons for this disparity not fully understood, but another recent study suggests that negative community attitudes toward and secrecy about homosexuality may be a contributing factor.
FDA Grants Fast-track Status for Tenofovir Microbicide Gel for HIV Prevention
- Details
- Category: Microbicides
- Published on Tuesday, 02 November 2010 14:17
- Written by CONRAD
CONRAD, an agency spearheading research on microbicides to help prevent sexual transmission of HIV, last week announced that the U.S. Food and Drug Administration (FDA) has granted "fast track" status to enable quicker review of studies looking at 1% tenofovir gel, which reduced women's risk of HIV infection by 39% in the Phase 2 CAPRISA trial that garnered worldwide headlines at the International AIDS Conference (AIDS 2010) this summer in Vienna.
U.S. Conference on AIDS Calls for Community Mobilization to Improve HIV Prevention, Testing, and Care
- Details
- Category: HIV Treatment
- Published on Friday, 24 September 2010 14:17
- Written by USCA
Participants at the U.S. Conference on AIDS, held last week in Orlando, and the National Minority AIDS Council produced a public service announcement calling for expanded HIV prevention, testing, care, and treatment. The video supports community mobilization, but also emphasizes the steps one person can take.
Non-stick Coating Added to Semen Protein May Help Reduce HIV Infection
- Details
- Category: HIV Prevention
- Published on Friday, 15 October 2010 14:17
- Written by UCSD
Researchers have found that applying a non-stick coating to amyloid protein fragments in the semen known as semen-derived enhancer of virus infection, or SEVI, may help prevent HIV from entering T-cells, according to a study published in the September 10, 2010 advance online edition of the Journal of Biological Chemistry. The non-stick amyloid-binding molecule BTA-EG6 -- initially developed as a therapy for Alzheimer's disease -- interferes with SEVI's ability to attract HIV particles and may have potential for use as a microbicide to prevent infection.
Global HIV Vaccine Enterprise Publishes Plan to Expand Research
- Details
- Category: HIV Vaccines
- Published on Friday, 10 September 2010 14:17
- Written by Global HIV Vaccine
The Global HIV Vaccine Enterprise -- an alliance of researchers, advocates, and funding sources around the world dedicated to accelerating development of a preventive HIV vaccine -- this week released a new plan for faster and more efficient research. The Enterprise Scientific Strategic Plan, published in the September 2010 issue of Nature Medicine, aims to translate recent advances in the field into "faster, smarter and more productive" vaccine research.
More Articles...
- AIDS 2010: Oral Tenofovir for Pre-exposure Prophylaxis Appears Safe and Does Not Discourage Safer Sex
- AIDS 2010: Early Antiretroviral Treatment Reduces New HIV Infections, Says British Columbia Study
- CAPRISA Microbicide Trial Shows Tenofovir Vaginal Gel Reduces HIV Transmission Risk by 39%
- Experts Call for 'New Era' of Unified HIV Vaccine Research
Web Design and Development by